Shire to fight FDA withdrawal of ProAmatine

Shire is appealing a proposal to withdraw ProAmatine, a drug for low blood pressure that won its original approval through the FDA's accelerated process. Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.